Syros Pharmaceuticals Inc (SYRS) recent quarterly performance of -89.70% is not showing the real picture
Syros Pharmaceuticals Inc (NASDAQ: SYRS) open the trading on Thursday, with a bit cautious approach as it glided -13.90% to $0.20, before settling in for